We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Max Healthcare Institute Limited provides healthcare services in India. It offers services in various specialties, including cancer care/oncology, cardiac sciences, neuro sciences, liver transplant and biliary sciences, orthopaedics, nephrology, kidney transplant, bone marrow transplant, bariatric/weight loss surgery, minimal access/laparoscopic surgery, urology, gastroenterology, and aesthetic and reconstructive surgery. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. As of August 27, 2021, it operated a network of 17 healthcare facilities, including tertiary and quaternary care hospitals at Saket, Patparganj, Vaishali, Rajendra Place, and Shalimar Bagh in Delhi National Capital Region; one each in Mumbai, Mohali, Bathinda, and Dehradun; a secondary care hospital in Gurugram; and day care centres at Noida, Lajpat Nagar, and Panchsheel Park in Delhi National Capital Region and one in Mohali, Punjab. The company is based in Gurugram, India.
TODAY'S HIGH
373.8
TODAY'S LOW
364
52 WEEK HIGH
458.05
52 WEEK LOW
256.95
% of Shares Held by
All Insider
33.42%
% of Shares Held by
Institutions
66.71%
% of Float Held by
Institutions
100.18%
Number of Institutions
Holding Shares
71
MARKET CAP
35386.79 Cr.
ETERPRISE VALUE
35855.94 Cr.
NO. OF SHARES
96.96 Cr.
BOOK VALUE
64.993
DIV. YIELD
None%
DEBT
913.38 Cr.
GROSS PROFIT
2248.64 Cr.
CASH
499.30 Cr.
REVENUE
3931.45 Cr.
REVENUE/SHARE
40.611
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | 0 | 0 | 0 | 75.76 Cr. |
| Change To Liabilities | 0 | -477.90 Cr. | -11.89 Cr. | 28.12 Cr. |
| Total cashflows from Investing Activities | 0 | -73 Cr. | -2640.70 Cr. | -16.53 Cr. |
| Net Borrowings | 0 | -816.83 Cr. | 576.16 Cr. | 22.23 Cr. |
| Total Cash from Financing Activities | 0 | 191.33 Cr. | 2353.12 Cr. | -73.95 Cr. |
| Other Liabilities | 0 | 28.34 Cr. | 16.52 Cr. | -71 Lakhs |
| Total Assets | 0 | 1179.16 Cr. | 1857.52 Cr. | 1857.52 Cr. |
| Net Income | 0 | -137.55 Cr. | 58.99 Cr. | -3.01 Cr. |
| Change in Cash | 0 | 515.58 Cr. | -210.49 Cr. | -1.53 Cr. |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 0 | 117.86 Cr. | 77.09 Cr. | 88.95 Cr. |
| Depreciation | 0 | 166.97 Cr. | 44.28 Cr. | 95.37 Cr. |
| Other Cashflows from Investing Activities | 0 | 66.08 Cr. | 25.37 Cr. | 45.35 Cr. |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Change to Inventory | 0 | 17.25 Cr. | -12.04 Cr. | 2.26 Cr. |
| Change to Account Receivables | 0 | 56.06 Cr. | -31.43 Cr. | -77.80 Cr. |
| Other Cashflows from Financing Activities | 0 | -171 Cr. | -80.56 Cr. | -96.18 Cr. |
| Change to Net Income | 0 | 457.57 Cr. | 11.30 Cr. | 37.45 Cr. |
| Capital Expenditures | 0 | -118.42 Cr. | -90.09 Cr. | -115.73 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 0 | -91.70 Cr. | 58.86 Cr. | 8.32 Cr. |
| Minority Interest | None | None | None | None |
| Net Income | 0 | 243.05 Cr. | 48.22 Cr. | 56.91 Cr. |
| Selling General Administrative | 0 | 565.67 Cr. | 304.85 Cr. | 62.33 Cr. |
| Gross Profit | 0 | 1275.53 Cr. | 590.11 Cr. | 850.98 Cr. |
| Ebit | 0 | 243.05 Cr. | 48.22 Cr. | 56.91 Cr. |
| Operating Income | 0 | 243.05 Cr. | 48.22 Cr. | 56.91 Cr. |
| Other Operating Expenses | 0 | 260.42 Cr. | 191.40 Cr. | 615.51 Cr. |
| Interest Expense | 0 | -171 Cr. | -78.19 Cr. | -96.18 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 0 | 45.85 Cr. | -13 Lakhs | 8.51 Cr. |
| Total Revenue | 0 | 2507.97 Cr. | 1059.03 Cr. | 1693.87 Cr. |
| Total Operating Expenses | 0 | 2264.92 Cr. | 1010.81 Cr. | 1636.96 Cr. |
| Cost of Revenue | 0 | 1232.44 Cr. | 468.92 Cr. | 842.89 Cr. |
| Total Other Income Expense Net | 0 | -334.75 Cr. | 10.64 Cr. | -48.59 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 0 | -137.55 Cr. | 58.99 Cr. | -19 Lakhs |
| Net Income Applicable to Common Shares | 0 | -137.55 Cr. | 58.99 Cr. | -3.01 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 0 | 2333.74 Cr. | 142.60 Cr. | 969.84 Cr. |
| Capital Surplus | 0 | 5104.81 Cr. | 2340.45 Cr. | 1076.78 Cr. |
| Total Liabilities | 0 | 2905.76 Cr. | 1420.51 Cr. | 2402.43 Cr. |
| Stock Holder Equity | 0 | 5638.68 Cr. | 2553.15 Cr. | 963.19 Cr. |
| Minority Interest | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 159.77 Cr. | 37.96 Cr. | 696.35 Cr. |
| Total Assets | 0 | 8544.44 Cr. | 3973.66 Cr. | 3365.62 Cr. |
| Common Stock | 0 | 965.95 Cr. | 537.24 Cr. | 537.24 Cr. |
| Retained Earnings | 0 | -458.59 Cr. | -324.54 Cr. | -444.08 Cr. |
| Other Liabilities | 0 | 1116.02 Cr. | 289.88 Cr. | 372.34 Cr. |
| Good Will | 0 | 2454.66 Cr. | 417.58 Cr. | 285.39 Cr. |
| Treasury Stock | 0 | 26.51 Cr. | 0 | -206.75 Cr. |
| Other Assets | 0 | 855.62 Cr. | 177.31 Cr. | 638.42 Cr. |
| Cash | 0 | 626.59 Cr. | 111.01 Cr. | 7.60 Cr. |
| Current Liabilities | 0 | 776.93 Cr. | 1009.95 Cr. | 1140.03 Cr. |
| Long Term Asset Charges | 0 | 98 Lakhs | 0 | 11.08 Cr. |
| Short Long Term Debt | 0 | 23.28 Cr. | 21.56 Cr. | 37.91 Cr. |
| Other Stockholder Equity | 0 | 26.51 Cr. | 0 | -206.75 Cr. |
| Property Plant Equipment | 0 | 1774.91 Cr. | 318.32 Cr. | 1024.16 Cr. |
| Total Cur. Assets | 0 | 1124.47 Cr. | 2915.39 Cr. | 447.30 Cr. |
| Long Term Investments | 0 | 1.04 Cr. | 2.46 Cr. | 51 Lakhs |
| Net Tangible Assets | 0 | 850.28 Cr. | 1992.97 Cr. | -292.04 Cr. |
| Short Term Investments | 0 | 20 Lakhs | 2182.36 Cr. | 0 |
| Net Receivables | 0 | 393.53 Cr. | 566.39 Cr. | 389.50 Cr. |
| Long Term Debt | 0 | 842.82 Cr. | 106.23 Cr. | 888.63 Cr. |
| Inventory | 0 | 53.80 Cr. | 26.80 Cr. | 26.01 Cr. |
| Accounts Payable | 0 | 435.69 Cr. | 179.63 Cr. | 291.59 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account